CorMedix Inc. (CRMD) › Shareholders' EquityCorMedix Inc. (CRMD) — Shareholders' EquityAnnual figures by period end, from SEC filings.2006-12-31: -$966.2K2007-12-31: -$4.40M2008-12-31: -$12.03M2009-12-31: -$14.71M2010-12-31: $7.26M2011-12-31: $1.33M2012-12-31: -$335.4K2013-12-31: -$4.02M2014-12-31: $3.63M2015-12-31: $34.01M2016-12-31: $17.81M2017-12-31: $7.19M2018-12-31: $4.93M2019-12-31: $23.65M2020-12-31: $44.22M2021-12-31: $62.80M2022-12-31: $55.06M2023-12-31: $70.14M2024-12-31: $84.66M2025-12-31: $405.31M$405.31M2006-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$405.31M+378.8%2026-03-05Balance as of period end2024-12-31$84.66M+20.7%2026-03-05Balance as of period end2023-12-31$70.14M+27.4%2026-03-05Balance as of period end2022-12-31$55.06M-12.3%2025-03-25Balance as of period end2021-12-31$62.80M+42.0%2024-03-12Balance as of period end2020-12-31$44.22M+87.0%2023-03-30Balance as of period end2019-12-31$23.65M+379.2%2022-03-29Balance as of period end2018-12-31$4.93M-31.4%2021-03-30Balance as of period end2017-12-31$7.19M-59.6%2020-03-16Balance as of period end2016-12-31$17.81M-47.6%2019-05-29Balance as of period end2015-12-31$34.01M+835.8%2018-03-19Balance as of period end2014-12-31$3.63M—2017-03-16Balance as of period end2013-12-31-$4.02M—2017-03-16Balance as of period end2012-12-31-$335.4K-125.2%2015-03-12Balance as of period end2011-12-31$1.33M-81.6%2014-03-04Balance as of period end2010-12-31$7.26M—2013-03-27Balance as of period end2009-12-31-$14.71M—2013-03-27Balance as of period end2008-12-31-$12.03M—2013-03-27Balance as of period end2007-12-31-$4.40M—2013-03-27Balance as of period end2006-12-31-$966.2K—2013-03-27Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)